174 related articles for article (PubMed ID: 37727982)
1. Telomere dysfunction in Tert knockout mice delays Braf
Zhang J; Zhang F; Porter KI; Dakup PP; Wang S; Robertson GP; Gaddameedhi S; Zhu J
Int J Cancer; 2024 Feb; 154(3):548-560. PubMed ID: 37727982
[TBL] [Abstract][Full Text] [Related]
2. Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53.
Viros A; Sanchez-Laorden B; Pedersen M; Furney SJ; Rae J; Hogan K; Ejiama S; Girotti MR; Cook M; Dhomen N; Marais R
Nature; 2014 Jul; 511(7510):478-482. PubMed ID: 24919155
[TBL] [Abstract][Full Text] [Related]
3. Loss of ARF sensitizes transgenic BRAFV600E mice to UV-induced melanoma via suppression of XPC.
Luo C; Sheng J; Hu MG; Haluska FG; Cui R; Xu Z; Tsichlis PN; Hu GF; Hinds PW
Cancer Res; 2013 Jul; 73(14):4337-48. PubMed ID: 23650282
[TBL] [Abstract][Full Text] [Related]
4. UV and melanoma: the TP53 link.
Choi YS; Fisher DE
Cell Res; 2014 Oct; 24(10):1157-8. PubMed ID: 25033756
[TBL] [Abstract][Full Text] [Related]
5. Ppp6c haploinsufficiency accelerates UV-induced BRAF(V600E)-initiated melanomagenesis.
Kanazawa K; Kishimoto K; Nomura M; Kurosawa K; Kato H; Inoue Y; Miura K; Fukui K; Yamashita Y; Sato I; Tsuji H; Watanabe T; Tanaka T; Yasuda J; Tanuma N; Shima H
Cancer Sci; 2021 Jun; 112(6):2233-2244. PubMed ID: 33743547
[TBL] [Abstract][Full Text] [Related]
6.
Tan J; Liu R; Zhu G; Umbricht CB; Xing M
Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15846-15851. PubMed ID: 32561648
[TBL] [Abstract][Full Text] [Related]
7. KIT Suppresses BRAF
Neiswender JV; Kortum RL; Bourque C; Kasheta M; Zon LI; Morrison DK; Ceol CJ
Cancer Res; 2017 Nov; 77(21):5820-5830. PubMed ID: 28947418
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis.
Werner C; Gensch C; Pöss J; Haendeler J; Böhm M; Laufs U
Atherosclerosis; 2011 May; 216(1):23-34. PubMed ID: 21396644
[TBL] [Abstract][Full Text] [Related]
9. In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF
Nasirden A; Saito T; Fukumura Y; Hara K; Akaike K; Kurisaki-Arakawa A; Asahina M; Yamashita A; Tomomasa R; Hayashi T; Arakawa A; Yao T
Virchows Arch; 2016 Dec; 469(6):687-696. PubMed ID: 27718012
[TBL] [Abstract][Full Text] [Related]
10. Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice.
Goel VK; Ibrahim N; Jiang G; Singhal M; Fee S; Flotte T; Westmoreland S; Haluska FS; Hinds PW; Haluska FG
Oncogene; 2009 Jun; 28(23):2289-98. PubMed ID: 19398955
[TBL] [Abstract][Full Text] [Related]
11. Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas.
Li Y; Cheng HS; Chng WJ; Tergaonkar V
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14402-14407. PubMed ID: 27911794
[TBL] [Abstract][Full Text] [Related]
12. TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation.
Vallarelli AF; Rachakonda PS; André J; Heidenreich B; Riffaud L; Bensussan A; Kumar R; Dumaz N
Oncotarget; 2016 Aug; 7(33):53127-53136. PubMed ID: 27449293
[TBL] [Abstract][Full Text] [Related]
13. Whole-genome landscapes of major melanoma subtypes.
Hayward NK; Wilmott JS; Waddell N; Johansson PA; Field MA; Nones K; Patch AM; Kakavand H; Alexandrov LB; Burke H; Jakrot V; Kazakoff S; Holmes O; Leonard C; Sabarinathan R; Mularoni L; Wood S; Xu Q; Waddell N; Tembe V; Pupo GM; De Paoli-Iseppi R; Vilain RE; Shang P; Lau LMS; Dagg RA; Schramm SJ; Pritchard A; Dutton-Regester K; Newell F; Fitzgerald A; Shang CA; Grimmond SM; Pickett HA; Yang JY; Stretch JR; Behren A; Kefford RF; Hersey P; Long GV; Cebon J; Shackleton M; Spillane AJ; Saw RPM; López-Bigas N; Pearson JV; Thompson JF; Scolyer RA; Mann GJ
Nature; 2017 May; 545(7653):175-180. PubMed ID: 28467829
[TBL] [Abstract][Full Text] [Related]
14. p53 Reactivation by PRIMA-1(Met) (APR-246) sensitises (V600E/K)BRAF melanoma to vemurafenib.
Krayem M; Journe F; Wiedig M; Morandini R; Najem A; Salès F; van Kempen LC; Sibille C; Awada A; Marine JC; Ghanem G
Eur J Cancer; 2016 Mar; 55():98-110. PubMed ID: 26790143
[TBL] [Abstract][Full Text] [Related]
15.
Bai X; Kong Y; Chi Z; Sheng X; Cui C; Wang X; Mao L; Tang B; Li S; Lian B; Yan X; Zhou L; Dai J; Guo J; Si L
Clin Cancer Res; 2017 Oct; 23(20):6120-6127. PubMed ID: 28720667
[No Abstract] [Full Text] [Related]
16. UV light-induced dual promoter mutations dismantle the telomeric guardrails in melanoma.
Sanford SL; Opresko PL
DNA Repair (Amst); 2023 Feb; 122():103446. PubMed ID: 36603239
[TBL] [Abstract][Full Text] [Related]
17. Telomere shortening produces an inflammatory environment that increases tumor incidence in zebrafish.
Lex K; Maia Gil M; Lopes-Bastos B; Figueira M; Marzullo M; Giannetti K; Carvalho T; Ferreira MG
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15066-15074. PubMed ID: 32554492
[TBL] [Abstract][Full Text] [Related]
18. A primary melanoma and its asynchronous metastasis highlight the role of BRAF, CDKN2A, and TERT.
Hosler GA; Davoli T; Mender I; Litzner B; Choi J; Kapur P; Shay JW; Wang RC
J Cutan Pathol; 2015 Feb; 42(2):108-17. PubMed ID: 25407517
[TBL] [Abstract][Full Text] [Related]
19. Telomere length and telomerase activity impact the UV sensitivity syndrome xeroderma pigmentosum C.
Stout GJ; Blasco MA
Cancer Res; 2013 Mar; 73(6):1844-54. PubMed ID: 23288511
[TBL] [Abstract][Full Text] [Related]
20. Telomerase is required for zebrafish lifespan.
Henriques CM; Carneiro MC; Tenente IM; Jacinto A; Ferreira MG
PLoS Genet; 2013; 9(1):e1003214. PubMed ID: 23349637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]